MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Abbott pledges funding to increase clinical trial diversity

Abbott pledges funding to increase clinical trial diversity

By

A researcher at the Morehouse School of Medicine
A researcher at the Morehouse School of Medicine [Photo courtesy of Morehouse School of Medicine]
Abbott Laboratories (NYSE:ABT) today announced $5 million in scholarships to promote diversity in the next generation of clinical trial leaders as part of an initiative to improve healthcare for all.

The Abbott Park, Illinois-based developer and manufacturer of medical devices and drugs said its initiative also includes forming the Diversity in Research Medical Advisory Board, funding improved access for women and under-represented communities in Abbott trials, and convening patient advocates, industry experts, trialists and physicians to develop and share ways to increase clinical trial diversity.

Get the full story at our sister site, Medical Design & Outsourcing.

More recent news

About Jim Hammerand

Jim Hammerand is the managing editor of Arrowfly's MassDevice and Medical Design & Outsourcing, where he leads coverage of medtech innovation, design, engineering and manufacturing. He also contributes to our Devicetalks podcasts and live events. Hammerand has more than two decades of journalism experience spanning newspapers, magazines, websites, live events, radio and TV news. For nearly a decade, Hammerand reported and edited business news for American City Business Journals as a reporter and digital editor at the Minneapolis/St. Paul Business Journal and then as managing editor of the Puget Sound Business Journal in Seattle. He holds degrees in journalism and management from the University of Minnesota and has won journalism awards from the Society of Professional Journalists, American Society of Business Publication Editors, and Trade, Association, Business Publications International. Connect with him on LinkedIn or by email at [email protected].